Business Description
TYK Medicines Inc
ISIN : CNE100006L34
Share Class Description:
HKSE:02410: Ordinary Shares - Class HTotal Employee Number:
173Compare
Compare
Traded in other countries / regions
02410.Hong Kong Index Membership
Hong Kong Stock Connect IPO Date
2024-08-20Description
TYK Medicines Inc is a clinical-stage biopharmaceutical company. The company is engaged in drug discovery research and development. The company and its subsidiaries are principally engaged in the research, development, and commercialization of pharmaceutical products. The company has built a pipeline with10 drug candidates, including Core Product TY-9591, five clinical stage products, and four preclinical stage or early clinical development stage.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.07 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 0.53 | |||||
Debt-to-EBITDA | -0.58 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 3.7 | |||||
3-Year EPS without NRI Growth Rate | 1.1 | |||||
3-Year FCF Growth Rate | 6.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 35.45 | |||||
9-Day RSI | 42.96 | |||||
14-Day RSI | 45.43 | |||||
3-1 Month Momentum % | -42.35 | |||||
6-1 Month Momentum % | -54.7 | |||||
12-1 Month Momentum % | -71.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.43 | |||||
Quick Ratio | 1.43 | |||||
Cash Ratio | 1.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.7 | |||||
Shareholder Yield % | -5.9 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -81.94 | |||||
ROA % | -36.55 | |||||
ROIC % | -54.89 | |||||
3-Year ROIIC % | 8.57 | |||||
ROC (Joel Greenblatt) % | -145.78 | |||||
ROCE % | -54.12 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 8.11 | |||||
Price-to-Tangible-Book | 11.35 | |||||
EV-to-EBIT | -7.9 | |||||
EV-to-EBITDA | -8.64 | |||||
EV-to-FCF | -10.66 | |||||
Earnings Yield (Greenblatt) % | -12.66 | |||||
FCF Yield % | -9.06 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TYK Medicines Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | |||
| EPS (TTM) (HK$) | -0.88 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 53.93 | ||
| 14-Day RSI | 45.43 | ||
| 14-Day ATR (HK$) | 0.678688 | ||
| 20-Day SMA (HK$) | 7.3015 | ||
| 12-1 Month Momentum % | -71.77 | ||
| 52-Week Range (HK$) | 5.35 - 22.56 | ||
| Shares Outstanding (Mil) | 384.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TYK Medicines Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TYK Medicines Inc Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
TYK Medicines Inc Frequently Asked Questions
What is TYK Medicines Inc(HKSE:02410)'s stock price today?
The current price of HKSE:02410 is HK$6.81. The 52 week high of HKSE:02410 is HK$22.56 and 52 week low is HK$5.35.
When is next earnings date of TYK Medicines Inc(HKSE:02410)?
The next earnings date of TYK Medicines Inc(HKSE:02410) is .
Does TYK Medicines Inc(HKSE:02410) pay dividends? If so, how much?
TYK Medicines Inc(HKSE:02410) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on TYK Medicines Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers